Riskpilot← Back to searchSign inGet full accessEYS AS
ASActiveOrg 916920989Øvre Slottsgate 18, 0157 OsloBusiness and other management consultancy activities · NACE 7020Est. 20165 employees
Revenue 2024
NOK 9,1M
-1% vs 2023
EBITDA margin
-39.4%
-286% vs 2023
Equity ratio
67.3%
Financial strength
Net profit 2024
NOK -3,6M
-298% vs 2023
| Revenue | NOK 9,1M | -1% |
| EBITDA | NOK -3,6M | -286% |
| Net profit | NOK -3,6M | -298% |
| Total assets | NOK 5,3M | -36% |
| Equity | NOK 3,6M | -50% |
| Employees | 5 | — |
Legal name
EYS AS
Org number
916920989
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
21. mars 2016
Share capital
NOK 741 150
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Rådgivning innenfor helsesektoren.
Address
Øvre Slottsgate 18, 0157 Oslo
Phone
+4740639681
Email
hello@eyecheck-system.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 100 | 594 | 295 | 452 | 247 | 708 | 3 076 | 9 207 | 9 091 |
| Staff expenses | −0 | −89 | −161 | −1 | −2 | −644 | −1 301 | −2 838 | −4 603 |
| EBITDA | −993 | −1 220 | −1 585 | −519 | −1 784 | −1 186 | −771 | 1 924 | −3 585 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −993 | −1 220 | −1 585 | −519 | −1 784 | −1 186 | −771 | 1 924 | −3 585 |
| Net financials | 0 | 0 | −3 | 0 | 1 | −77 | −33 | −85 | −59 |
| Profit before tax | −993 | −1 220 | −1 588 | −519 | −1 783 | −1 263 | −804 | 1 839 | −3 644 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −993 | −1 220 | −1 588 | −519 | −1 783 | −1 263 | −804 | 1 839 | −3 644 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 81 | 420 | 641 | 748 | 371 | 2 209 | 1 814 | 8 307 | 5 321 |
| Equity | −393 | −1 613 | −3 201 | 301 | −1 | 1 435 | 384 | 7 223 | 3 579 |
| Long-term debt | 0 | 1 800 | 3 300 | 314 | 314 | 313 | 313 | 0 | 0 |
| Short-term debt | 474 | 233 | 541 | 134 | 59 | 461 | 1 117 | 1 083 | 1 742 |
| Total debt | 474 | 2 033 | 3 841 | 448 | 373 | 774 | 1 430 | 1 083 | 1 742 |
EBITDA margin
-39.4%
This company
15.8%
Market median
-349% vs market
20162024
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20162024
Return on equity
-101.8%
This company
18.4%
Market median
-653% vs market
20162024
Net profit margin
-40.1%
This company
8.1%
Market median
-595% vs market
20162024
Asset turnover
1.71×
This company
1.12×
Market median
+53% vs market
20162024
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20162024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CC Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
RK Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
SE Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gynoculus As | Company | 55.0% | 55.0% | 2023 |
Meiberg As | Company | 18.6% | 18.6% | 2023 |
Vismed Holding As | Company | 5.3% | 5.3% | 2023 |
Thomsen Holding As | Company | 5.2% | 5.2% | 2023 |
Hartmann Invest As | Company | 3.9% | 3.9% | 2023 |
Archon I As | Company | 3.3% | 3.3% | 2023 |
Myva As | Company | 2.6% | 2.6% | 2023 |
Iso Industri Service As | Company | 1.7% | 1.7% | 2023 |
Ahan As | Company | 1.4% | 1.4% | 2023 |
Eys As | Company | 1.2% | 1.2% | 2023 |
Hartmann Eiendomsutvikling As | Company | 1.0% | 1.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gynoculus As
EYS AS Board members of EYS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Caroline Cecilie Skogland Kverne | Chief Executive Officer | 0 companies |
| Rasmus Kokou Heim | Chief Executive Officer | 0 companies |
| Sondre Enger Beckrøge | Chief Executive Officer | 0 companies |
| Jørn Beckrøge | Chairman | 0 companies |
| Ulf Kurt Jørn Müller-Henneberg | Board of Directors | 0 companies |
| Peter Tang Thomsen | Chairman | 0 companies |
| Geir Hartmann | Board of Directors | 0 companies |
| Tor Malmo | Board of Directors | 0 companies |
| Morten Pensgård Gundersen | Board of Directors | 0 companies |
| Andre Hansen | Chairman | 0 companies |
| Dag Tjernsmo | Chairman | 0 companies |